| 1 | Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival. (Leung PY, Chen W, Sari AN, Sitaram P, Wu PK, Tsai S, Park JI) World J Gastroenterol 2024 Feb 21;30(7):714-727 |
| 1 | Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy. (Smith ZL, Thorgerson AM, Dawson AZ, Wani S) Dig Dis Sci 2023 Dec;68(12):4439-4448 2 Citations |
| 1 | Prostate Adenocarcinoma Metastasis to the Rectal Submucosa and Mesorectal Lymph Node on 18 F-PSMA PET/CT. (Segal E, Dababo N, Bhalla D, Bucklan D) Clin Nucl Med 2023 Oct 01;48(10):e506-e508 |
| 1 | Determination of "borderline resectable" pancreatic cancer - A global assessment of 30 shades of grey. (Badgery HE, Muhlen-Schulte T, Zalcberg JR, D'souza B, Gerstenmaier JF, Pickett C, Samra J, Croagh D, Pancreatic Cancer Image Biobank Authorship Group) HPB (Oxford) 2023 Nov;25(11):1393-1401 4 Citations |
| 1 | Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma. (Hall WA, Li J, You YN, Gollub MJ, Grajo JR, Rosen M, dePrisco G, Yothers G, Dorth JA, Rahma OE, Russell MM, Gross HM, Jacobs SA, Faller BA, George S, Al Baghdadi T, Haddock MG, Valicenti R, Hong TS, George TJ) J Clin Oncol 2023 Oct 10;41(29):4643-4651 4 Citations |
| 1 | Cancer Risk in Barrett's Esophagus: A Clinical Review. (Beydoun AS, Stabenau KA, Altman KW, Johnston N) Int J Mol Sci 2023 Mar 23;24(7) 6 Citations |
| 4 | Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S) J Surg Oncol 2023 Jul;128(1):41-50 2 Citations |
| 3 | A Randomized, Phase II, Clinical Trial of Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable, Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma. (Saif A, Verbus E, Erickson B, Kamgar M, Tsai S, Evans D, Hernandez JM, Hall WA) Ann Surg Oncol 2023 Feb;30(2):688-690 |
| 1 | Achieving a Cure Without Total Mesorectal Excision in Rectal Adenocarcinoma. (Hall WA, Smith JJ) J Clin Oncol 2023 Jan 10;41(2):173-180 4 Citations |
| 1 | Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study. (Turner KM, Morris MC, Delman AM, Hanseman D, Johnston FM, Greer J, Walle KV, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Maduekwe U, Kothari A, Staley CA, Maithel SK, Lambert LA, Kim AC, Cloyd JM, Wilson GC, Sussman JJ, Ahmad SA, Patel SH) J Gastrointest Surg 2022 Dec;26(12):2569-2578 2 Citations |
| 1 | Oncocytic nodular hyperplasia of the thyroid. (Suster D, Ronen N, Giorgadze T) Ann Diagn Pathol 2022 Dec;61:152049 |
| 1 | Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium. (Kelly KN, Macedo FI, Seaton M, Wilson G, Hammill C, Martin RC, Maduekwe UN, Kim HJ, Maithel SK, Abbott DE, Ahmad SA, Kooby DA, Merchant NB, Datta J) Ann Surg Oncol 2022 Sep;29(9):6004-6012 3 Citations |
| 1 | Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma. (Mehtsun WT, McCleary NJ, Maduekwe UN, Wolpin BM, Schrag D, Wang J) JAMA Oncol 2022 Jan 01;8(1):88-95 10 Citations |
| 3 | Value of Neoadjuvant Radiation Therapy in the Management of Pancreatic Adenocarcinoma. (Hall WA, Dawson LA, Hong TS, Palta M, Herman JM, Evans DB, Tsai S, Ferrone CR, B Fleming J, Chang DT, Crane C, Koong AC, Oar A, Parikh P, Erickson B, Hoffe S, Goodman KA) J Clin Oncol 2021 Dec 01;39(34):3773-3777 16 Citations |
| 5 | Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology. (Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS) Cancer Metastasis Rev 2021 Sep;40(3):879-889 2 Citations |
| 1 | Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis. (Muraki T, Jang KT, Reid MD, Pehlivanoglu B, Memis B, Basturk O, Mittal P, Kooby D, Maithel SK, Sarmiento JM, Christians K, Tsai S, Evans D, Adsay V) Mod Pathol 2022 Jan;35(1):96-105 15 Citations |
| 2 | Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma. (Kamgar M, Chakrabarti S, Shreenivas A, George B) Surg Oncol Clin N Am 2021 Oct;30(4):673-691 1 Citation |
| 1 | Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database. (Fonseca AL, Cherla D, Kothari AN, Tzeng CD, Heslin MJ, Mehari KR, Johnston FM, Tran-Cao HS) Ann Surg Oncol 2022 Jan;29(1):342-351 18 Citations |
| 1 | SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer. (Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, Kurzrock R) JCI Insight 2021 Sep 22;6(18) 29 Citations |
| 1 | Surgical Eligibility Does Not Imply Surgical Equity: Recommendations for Curative Treatment in Patients With Stage I/II Pancreatic Head Adenocarcinoma Differ by Age and Race. (Hester CA, Kothari AN, Mason M, Maxwell J, Ikoma N, Kim MP, Tzeng CD, Lee JE, Katz MHG, Cao HST) Ann Surg 2023 Feb 01;277(2):321-328 5 Citations |
| 1 | Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance. (Kaoutari AE, Fraunhoffer NA, Hoare O, Teyssedou C, Soubeyran P, Gayet O, Roques J, Lomberk G, Urrutia R, Dusetti N, Iovanna J) EBioMedicine 2021 Apr;66:103332 23 Citations |
| 6 | Long-Term Outcomes of Dose-Escalated Pelvic Lymph Node Intensity-Modulated Radiation Therapy (IMRT) With a Simultaneous Hypofractionated Boost to the Prostate for Very High-Risk Adenocarcinoma of the Prostate: A Prospective Phase II Clinical Trial. (Hall WA, Bedi M, Kilari D, Bylow KA, Burfeind J, Johnstone C, Siker M, Currey A, See WA, Nelson A, Johnson S, Straza M, Lawton CAF) Pract Radiat Oncol 2021;11(6):527-533 3 Citations |
| 1 | Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer. (Baca SC, Takeda DY, Seo JH, Hwang J, Ku SY, Arafeh R, Arnoff T, Agarwal S, Bell C, O'Connor E, Qiu X, Alaiwi SA, Corona RI, Fonseca MAS, Giambartolomei C, Cejas P, Lim K, He M, Sheahan A, Nassar A, Berchuck JE, Brown L, Nguyen HM, Coleman IM, Kaipainen A, De Sarkar N, Nelson PS, Morrissey C, Korthauer K, Pomerantz MM, Ellis L, Pasaniuc B, Lawrenson K, Kelly K, Zoubeidi A, Hahn WC, Beltran H, Long HW, Brown M, Corey E, Freedman ML) Nat Commun 2021 Mar 30;12(1):1979 58 Citations |
| 1 | Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts. (Iczkowski KA, van Leenders GJLH, Tarima S, Wu R, Van der Kwast T, Berney DM, Evans AJ, Wheeler TM, Ro JY, Samaratunga H, Delahunt B, Srigley J, Varma M, Tsuzuki T, Egevad L) Ann Diagn Pathol 2021 Jun;52:151733 8 Citations |
| 1 | The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. (Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB) J Gastrointest Surg 2021 Nov;25(11):2908-2919 4 Citations |
| 2 | Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer. (Czaja RC, Tarima S, Wu R, Palagnmonthip W, Iczkowski KA) Ann Diagn Pathol 2021 Jun;52:151725 2 Citations |
| 1 | GATA4 blocks squamous epithelial cell gene expression in human esophageal squamous cells. (Stavniichuk R, DeLaForest A, Thompson CA, Miller J, Souza RF, Battle MA) Sci Rep 2021 Feb 05;11(1):3206 6 Citations |
| 1 | Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells. (Huang YW, Lin CW, Pan P, Shan T, Echeveste CE, Mo YY, Wang HT, Aldakkak M, Tsai S, Oshima K, Yearsley M, Xiao J, Cao H, Sun C, Du M, Bai W, Yu J, Wang LS) Front Immunol 2020;11:570683 11 Citations |
| 1 | Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. (Dong J, Maj C, Tsavachidis S, Ostrom QT, Gharahkhani P, Anderson LA, Wu AH, Ye W, Bernstein L, Borisov O, Schröder J, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, May A, Gerges C, Anders M, Venerito M, Schmidt T, Izbicki JR, Hölscher AH, Schumacher B, Vashist Y, Neuhaus H, Rösch T, Knapp M, Krawitz P, Böhmer A, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Corley DA, Gockel I, Fitzgerald RC, Stomach and Oesophageal Cancer Study (SOCS) consortium, Cook MB, Whiteman DC, Vaughan TL, Schumacher J, Thrift AP) Gastroenterology 2020 Dec;159(6):2065-2076.e1 13 Citations |
| 1 | The Complexity of Neoadjuvant Therapy for Operable Pancreatic Cancer: Lessons Learned From SWOG S1505. (Evans DB) Ann Surg 2020 Sep 01;272(3):487 11 Citations |
| 1 | What is causing this patient's severe pruritus? (Probst EA, Smith AL, Abad JD) JAAPA 2020 Jun;33(6):54-56 |
| 2 | Integrative pathway enrichment analysis of multivariate omics data. (Paczkowska M, Barenboim J, Sintupisut N, Fox NS, Zhu H, Abd-Rabbo D, Mee MW, Boutros PC, PCAWG Drivers and Functional Interpretation Working Group, Reimand J, PCAWG Consortium) Nat Commun 2020 Feb 05;11(1):735 95 Citations |
| 1 | Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus. (Craig MP, Rajakaruna S, Paliy O, Sajjad M, Madhavan S, Reddy N, Zhang J, Bottomley M, Agrawal S, Kadakia MP) Clin Transl Gastroenterol 2020 Jan;11(1):e00125 17 Citations |
| 2 | White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. (Kulkarni NM, Mannelli L, Zins M, Bhosale PR, Arif-Tiwari H, Brook OR, Hecht EM, Kastrinos F, Wang ZJ, Soloff EV, Tolat PP, Sangster G, Fleming J, Tamm EP, Kambadakone AR) Abdom Radiol (NY) 2020 Mar;45(3):729-742 23 Citations |
| 2 | White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. (Kulkarni NM, Soloff EV, Tolat PP, Sangster GP, Fleming JB, Brook OR, Wang ZJ, Hecht EM, Zins M, Bhosale PR, Arif-Tiwari H, Mannelli L, Kambadakone AR, Tamm EP) Abdom Radiol (NY) 2020 Mar;45(3):716-728 37 Citations |
| 2 | Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma. (Santofimia-Castaño P, Xia Y, Peng L, Velázquez-Campoy A, Abián O, Lan W, Lomberk G, Urrutia R, Rizzuti B, Soubeyran P, Neira JL, Iovanna J) Cells 2019 Nov 17;8(11) 30 Citations |
| 5 | Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. (Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S) Ann Surg Oncol 2019 Dec;26(13):4515-4521 7 Citations |
| 1 | Initial Experience With Staging Rectal Adenocarcinoma Using 7T Magnetic Resonance Imaging. (Blank J, Berger N, Knechtges P, Prost R, Peterson C, Ludwig K, Ridolfi T) J Surg Res 2020 Jan;245:434-440 1 Citation |
| 1 | Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. (Wei AC, Ou FS, Shi Q, Carrero X, O'Reilly EM, Meyerhardt J, Wolff RA, Kindler HL, Evans DB, Deshpande V, Misdraji J, Tamm E, Sahani D, Moore M, Newman E, Merchant N, Berlin J, Goff LW, Pisters P, Posner MC) Ann Surg Oncol 2019 Dec;26(13):4489-4497 19 Citations |
| 5 | Use of Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Rectal Cancer. (Hu KY, Simpson MT, Blank JJ, Szabo A, Eastwood D, Ludwig KA, Peterson CY, Ridolfi TJ) J Surg Res 2019 Nov;243:447-452 10 Citations |
| 1 | Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. (Seo DW, Sherman S, Dua KS, Slivka A, Roy A, Costamagna G, Deviere J, Peetermans J, Rousseau M, Nakai Y, Isayama H, Kozarek R, Biliary SEMS During Neoadjuvant Therapy Study Group) Gastrointest Endosc 2019 Oct;90(4):602-612.e4 64 Citations |
| 1 | Radiation therapy for pancreatic adenocarcinoma, a treatment option that must be considered in the management of a devastating malignancy. (Hall WA, Goodman KA) Radiat Oncol 2019 Jun 26;14(1):114 26 Citations |
| 1 | Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors. (Gallan AJ, Alexander E, Reid P, Kutuby F, Chang A, Henriksen KJ) Am J Kidney Dis 2019 Dec;74(6):853-856 55 Citations |
| 2 | Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1. (Zarnecki KG, Kristianto J, Charlson J, Wilson B, Blank RD, Shaker JL) Osteoporos Int 2019 Aug;30(8):1699-1703 3 Citations |
| 3 | Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma. (Samuels TL, Altman KW, Gould JC, Kindel T, Bosler M, MacKinnon A, Hagen CE, Johnston N) Laryngoscope 2019 Dec;129(12):2687-2695 15 Citations |
| 1 | A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. (Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, Schürch CM, Hamilton M, Robertson N, Lin W, Noel P, Wartenberg M, Zlobec I, Eichmann M, Galván JA, Karamitopoulou E, Gilderman T, Esparza LA, Shima Y, Spahn P, French R, Lewis NE, Fisch KM, Sasik R, Rosenthal SB, Kritzik M, Von Hoff D, Han H, Ideker T, Deshpande AJ, Lowy AM, Adams PD, Reya T) Cell 2019 Apr 18;177(3):572-586.e22 100 Citations |
| 1 | FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis. (Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK) Oncogene 2019 Jun;38(26):5265-5280 38 Citations |
| 1 | RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression. (Li Y, Xie N, Chen R, Lee AR, Lovnicki J, Morrison EA, Fazli L, Zhang Q, Musselman CA, Wang Y, Huang J, Gleave ME, Collins C, Dong X) Eur Urol 2019 Aug;76(2):157-166 20 Citations |
| 1 | Clinical determinants for successful circulating tumor DNA analysis in prostate cancer. (Schweizer MT, Gulati R, Beightol M, Konnick EQ, Cheng HH, Klemfuss N, De Sarkar N, Yu EY, Montgomery RB, Nelson PS, Pritchard CC) Prostate 2019 May;79(7):701-708 19 Citations |
| 1 | Sequential transplantation and implications for clinical management: OLT followed by HCT and consequent RT in a pediatric patient. (Hoogenboom L, Margolis D, Anderson L, Phelan R) Pediatr Transplant 2019 May;23(3):e13370 |
| 1 | No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. (Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC, Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP) Clin Gastroenterol Hepatol 2019 Oct;17(11):2227-2235.e1 15 Citations |
| 1 | A phase III, multicenter, prospective, single-blinded, noninferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video). (Dua KS, DeWitt JM, Kessler WR, Diehl DL, Draganov PV, Wagh MS, Kahaleh M, Wong Kee Song LM, Khara HS, Khan AH, Aburajab MM, Ballard D, Forsmark CE, Edmundowicz SA, Brauer BC, Tyberg A, Buttar NS, Adler DG) Gastrointest Endosc 2019 Jul;90(1):64-74.e3 11 Citations |
| 1 | Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. (Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD) HPB (Oxford) 2019 Jun;21(6):662-668 9 Citations |
| 4 | A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis. (Tsai S, McOlash L, Jia S, Zhang J, Simpson P, Kaldunski ML, Aldakkak M, Grewal J, Palen K, Dwinell MB, Johnson BD, Mackinnon A, Hessner MJ, Gershan JA) Cancer Epidemiol Biomarkers Prev 2019 Apr;28(4):680-689 2 Citations |
| 1 | Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion. (Han L, Gallan A, Paner GP) Am J Surg Pathol 2019 Apr;43(4):475-479 4 Citations |
| 5 | Distal splenorenal and mesocaval shunting at the time of pancreatectomy. (Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK) Surgery 2019 Feb;165(2):298-306 12 Citations |
| 1 | Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma. (Kato S, Okamura R, Baumgartner JM, Patel H, Leichman L, Kelly K, Sicklick JK, Fanta PT, Lippman SM, Kurzrock R) Clin Cancer Res 2018 Dec 15;24(24):6248-6256 81 Citations |
| 1 | Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. (Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM) Lancet Oncol 2018 Nov;19(11):1504-1515 160 Citations |
| 1 | Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells. (Choupani J, Alivand MR, M Derakhshan S, Zaeifizadeh M, S Khaniani M) J Cell Physiol 2019 Jun;234(6):9093-9104 26 Citations |
| 5 | Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2020 Apr;271(4):740-747 123 Citations |
| 1 | Primary peritoneal hepatoid adenocarcinoma: a diagnostic and therapeutic conundrum in patients with gastrointestinal bleeding. (Inayat F, Zafar F, Lodhi HT, Ullah W) BMJ Case Rep 2018 Sep 18;2018 1 Citation |
| 1 | Synchronous pancreatic tumors in a patient with history of Wilms tumor: A case of pancreatic adenocarcinoma and lipid-rich neuroendocrine tumor diagnosed by cytopathology. (Huang H, Giorgadze T) Diagn Cytopathol 2018 Oct;46(10):864-869 1 Citation |
| 5 | A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. (Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB) Ann Surg 2018 Oct;268(4):610-619 56 Citations |
| 1 | Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. (Dong J, Gu X, El-Serag HB, Thrift AP) Clin Gastroenterol Hepatol 2019 Mar;17(4):657-665.e13 19 Citations |
| 1 | miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation. (Zhang W, Chen JH, Shan T, Aguilera-Barrantes I, Wang LS, Huang TH, Rader JS, Sheng X, Huang YW) Lab Invest 2018 Nov;98(11):1397-1407 58 Citations |
| 1 | Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. (Liu Y, Sethi NS, Hinoue T, Schneider BG, Cherniack AD, Sanchez-Vega F, Seoane JA, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi RS, Rabkin CS, Willis JE, Wang KK, McCall SJ, Mishra L, Ojesina AI, Bullman S, Pedamallu CS, Lazar AJ, Sakai R, Cancer Genome Atlas Research Network, Thorsson V, Bass AJ, Laird PW) Cancer Cell 2018 Apr 09;33(4):721-735.e8 356 Citations |
| 1 | Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. (Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC, Stomach and Oesophageal Cancer Study (SOCS) Consortium, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP) Clin Gastroenterol Hepatol 2018 Oct;16(10):1598-1606.e4 13 Citations |
| 2 | Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors. (Pan P, Oshima K, Huang YW, Agle KA, Drobyski WR, Chen X, Zhang J, Yearsley MM, Yu J, Wang LS) Int J Cancer 2018 Aug 15;143(4):886-896 60 Citations |
| 5 | Locally advanced pancreas cancer: Staging and goals of therapy. (Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK) Surgery 2018 May;163(5):1053-1062 46 Citations |
| 1 | The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities. (Tesfaye AA, Kamgar M, Azmi A, Philip PA) Expert Rev Anticancer Ther 2018 Feb;18(2):131-148 32 Citations |
| 1 | Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. (Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC, Stomach and Oesophageal Cancer Study (SOCS) consortium, Whiteman DC, Vaughan TL, Thrift AP) Gastroenterology 2018 Apr;154(5):1273-1281.e3 63 Citations |
| 1 | Pancreatic adenocarcinoma: cross-sectional imaging techniques. (Kulkarni NM, Hough DM, Tolat PP, Soloff EV, Kambadakone AR) Abdom Radiol (NY) 2018 Feb;43(2):253-263 17 Citations |
| 1 | The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. (Koay EJ, Hall W, Park PC, Erickson B, Herman JM) Abdom Radiol (NY) 2018 Feb;43(2):393-403 6 Citations |
| 1 | NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. (Ratnam NM, Peterson JM, Talbert EE, Ladner KJ, Rajasekera PV, Schmidt CR, Dillhoff ME, Swanson BJ, Haverick E, Kladney RD, Williams TM, Leone GW, Wang DJ, Guttridge DC) J Clin Invest 2017 Oct 02;127(10):3796-3809 113 Citations |
| 1 | Conceptual and Experimental Tools to Understand Spatial Effects and Transport Phenomena in Nonlinear Biochemical Networks Illustrated with Patchy Switching. (Pompano RR, Chiang AH, Kastrup CJ, Ismagilov RF) Annu Rev Biochem 2017 Jun 20;86:333-356 8 Citations |
| 1 | Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma. (Schwaederlé MC, Patel SP, Husain H, Ikeda M, Lanman RB, Banks KC, Talasaz A, Bazhenova L, Kurzrock R) Clin Cancer Res 2017 Sep 01;23(17):5101-5111 112 Citations |
| 1 | Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. (Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J) Cancer 2017 Sep 15;123(18):3486-3493 87 Citations |
| 1 | Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. (Lawton CAF, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M 3rd, Kwok Y, Dignam JJ, Sandler HM) Int J Radiat Oncol Biol Phys 2017 Jun 01;98(2):296-303 99 Citations |
| 1 | Longitudinal thumbnail fissures due to erlotinib therapy for lung cancer. (Dasanu CA, Alvarez-Argote J, Lippman SM, Plaxe SC) J Oncol Pharm Pract 2018 Apr;24(3):229-231 2 Citations |
| 2 | Considerations Regarding the Role of Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma in the Elderly. (Hall WA, Erickson B) J Oncol Pract 2017 Mar;13(3):171-172 |
| 1 | Advances in the Diagnosis and Treatment of Barrett's Esophagus and Early Esophageal Cancer; Summary of the Kelly and Carlos Pellegrini SSAT/SAGES Luncheon Symposium. (Gould JC, Wendling MR, Oeschlager BK, Mittal SK, Komanduri S, Perry KA, Cleary S, Galandiuk S, Scott DJ, Fisichella PM, Shaheen NJ, Haisley KR, Hunter JG) J Gastrointest Surg 2017 Aug;21(8):1342-1349 4 Citations |
| 4 | Integrated genomic and molecular characterization of cervical cancer. (Cancer Genome Atlas Research Network, Albert Einstein College of Medicine, Analytical Biological Services, Barretos Cancer Hospital, Baylor College of Medicine, Beckman Research Institute of City of Hope, Buck Institute for Research on Aging, Canada's Michael Smith Genome Sciences Centre, Harvard Medical School, Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services, HudsonAlpha Institute for Biotechnology, ILSbio, LLC, Indiana University School of Medicine, Institute of Human Virology, Institute for Systems Biology, International Genomics Consortium, Leidos Biomedical, Massachusetts General Hospital, McDonnell Genome Institute at Washington University, Medical College of Wisconsin, Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Montefiore Medical Center, NantOmics, National Cancer Institute, National Hospital, Abuja, Nigeria, National Human Genome Research Institute, National Institute of Environmental Health Sciences, National Institute on Deafness &Other Communication Disorders, Ontario Tumour Bank, London Health Sciences Centre, Ontario Tumour Bank, Ontario Institute for Cancer Research, Ontario Tumour Bank, The Ottawa Hospital, Oregon Health &Science University, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, SRA International, St Joseph's Candler Health System, Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University, Research Institute at Nationwide Children's Hospital, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of Bergen, University of Texas MD Anderson Cancer Center, University of Abuja Teaching Hospital, University of Alabama at Birmingham, University of California, Irvine, University of California Santa Cruz, University of Kansas Medical Center, University of Lausanne, University of New Mexico Health Sciences Center, University of North Carolina at Chapel Hill, University of Oklahoma Health Sciences Center, University of Pittsburgh, University of São Paulo, Ribeir ão Preto Medical School, University of Southern California, University of Washington, University of Wisconsin School of Medicine &Public Health, Van Andel Research Institute, Washington University in St Louis) Nature 2017 Mar 16;543(7645):378-384 991 Citations |
| 3 | Recommendations for MRI-based contouring of gross tumor volume and organs at risk for radiation therapy of pancreatic cancer. (Heerkens HD, Hall WA, Li XA, Knechtges P, Dalah E, Paulson ES, van den Berg CAT, Meijer GJ, Koay EJ, Crane CH, Aitken K, van Vulpen M, Erickson BA) Pract Radiat Oncol 2017;7(2):126-136 40 Citations |
| 1 | Integrated genomic characterization of oesophageal carcinoma. (Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, Brigham and Women’s Hospital, Broad Institute, Brown University, Case Western Reserve University, Dana-Farber Cancer Institute, Duke University, Greater Poland Cancer Centre, Harvard Medical School, Institute for Systems Biology, KU Leuven, Mayo Clinic, Memorial Sloan Kettering Cancer Center, National Cancer Institute, Nationwide Children’s Hospital, Stanford University, University of Alabama, University of Michigan, University of North Carolina, University of Pittsburgh, University of Rochester, University of Southern California, University of Texas MD Anderson Cancer Center, University of Washington, Van Andel Research Institute, Vanderbilt University, Washington University, Genome Sequencing Center: Broad Institute, Washington University in St. Louis, Genome Characterization Centers: BC Cancer Agency, Broad Institute, Harvard Medical School, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, University of North Carolina, University of Southern California Epigenome Center, University of Texas MD Anderson Cancer Center, Van Andel Research Institute, Genome Data Analysis Centers: Broad Institute, Brown University:, Harvard Medical School, Institute for Systems Biology, Memorial Sloan Kettering Cancer Center, University of California Santa Cruz, University of Texas MD Anderson Cancer Center, Biospecimen Core Resource: International Genomics Consortium, Research Institute at Nationwide Children’s Hospital, Tissue Source Sites: Analytic Biologic Services, Asan Medical Center, Asterand Bioscience, Barretos Cancer Hospital, BioreclamationIVT, Botkin Municipal Clinic, Chonnam National University Medical School, Christiana Care Health System, Cureline, Duke University, Emory University, Erasmus University, Indiana University School of Medicine, Institute of Oncology of Moldova, International Genomics Consortium, Invidumed, Israelitisches Krankenhaus Hamburg, Keimyung University School of Medicine, Memorial Sloan Kettering Cancer Center, National Cancer Center Goyang, Ontario Tumour Bank, Peter MacCallum Cancer Centre, Pusan National University Medical School, Ribeirão Preto Medical School, St. Joseph’s Hospital &Medical Center, St. Petersburg Academic University, Tayside Tissue Bank, University of Dundee, University of Kansas Medical Center, University of Michigan, University of North Carolina at Chapel Hill, University of Pittsburgh School of Medicine, University of Texas MD Anderson Cancer Center, Disease Working Group: Duke University, Memorial Sloan Kettering Cancer Center, National Cancer Institute, University of Texas MD Anderson Cancer Center, Yonsei University College of Medicine, Data Coordination Center: CSRA Inc., Project Team: National Institutes of Health) Nature 2017 Jan 12;541(7636):169-175 1199 Citations |
| 1 | Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. (Seow WJ, Matsuo K, Hsiung CA, Shiraishi K, Song M, Kim HN, Wong MP, Hong YC, Hosgood HD 3rd, Wang Z, Chang IS, Wang JC, Chatterjee N, Tucker M, Wei H, Mitsudomi T, Zheng W, Kim JH, Zhou B, Caporaso NE, Albanes D, Shin MH, Chung LP, An SJ, Wang P, Zheng H, Yatabe Y, Zhang XC, Kim YT, Shu XO, Kim YC, Bassig BA, Chang J, Ho JC, Ji BT, Kubo M, Daigo Y, Ito H, Momozawa Y, Ashikawa K, Kamatani Y, Honda T, Sakamoto H, Kunitoh H, Tsuta K, Watanabe SI, Nokihara H, Miyagi Y, Nakayama H, Matsumoto S, Tsuboi M, Goto K, Yin Z, Shi J, Takahashi A, Goto A, Minamiya Y, Shimizu K, Tanaka K, Wu T, Wei F, Wong JY, Matsuda F, Su J, Kim YH, Oh IJ, Song F, Lee VH, Su WC, Chen YM, Chang GC, Chen KY, Huang MS, Yang PC, Lin HC, Xiang YB, Seow A, Park JY, Kweon SS, Chen CJ, Li H, Gao YT, Wu C, Qian B, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Tsai YH, Jung YJ, Guo H, Hu Z, Wang WC, Chung CC, Lawrence C, Burdett L, Yeager M, Jacobs KB, Hutchinson A, Berndt SI, He X, Wu W, Wang J, Li Y, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Hu L, Chen CH, Yang TY, Xu J, Guan P, Tan W, Wang CL, Sihoe AD, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chan JK, Chu M, Li YJ, Li J, Chen H, Yu CJ, Jin L, Lo YL, Chen YH, Fraumeni JF Jr, Liu J, Yamaji T, Yang Y, Hicks B, Wyatt K, Li SA, Dai J, Ma H, Jin G, Song B, Wang Z, Cheng S, Li X, Ren Y, Cui P, Iwasaki M, Shimazu T, Tsugane S, Zhu J, Jiang G, Fei K, Wu G, Chien LH, Chen HL, Su YC, Tsai FY, Chen YS, Yu J, Stevens VL, Laird-Offringa IA, Marconett CN, Lin D, Chen K, Wu YL, Landi MT, Shen H, Rothman N, Kohno T, Chanock SJ, Lan Q) Hum Mol Genet 2017 Jan 15;26(2):454-465 59 Citations |
| 2 | Loss of free fatty acid receptor 2 enhances colonic adenoma development and reduces the chemopreventive effects of black raspberries in ApcMin/+ mice. (Pan P, W Skaer C, Wang HT, Oshima K, Huang YW, Yu J, Zhang J, M Yearsley M, A Agle K, R Drobyski W, Chen X, Wang LS) Carcinogenesis 2017 Jan;38(1):86-93 38 Citations |
| 1 | Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. (Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE) J Gastrointest Surg 2017 Jan;21(1):164-174 112 Citations |
| 1 | Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection. (Gallan AJ, Antic T) Hum Pathol 2016 Nov;57:136-139 12 Citations |
| 1 | Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations. (Wang K, Russell JS, McDermott JD, Elvin JA, Khaira D, Johnson A, Jennings TA, Ali SM, Murray M, Marshall C, Oldham DS, Washburn D, Wong SJ, Chmielecki J, Yelensky R, Lipson D, Miller VA, Stephens PJ, Serracino HS, Ross JS, Bowles DW) Clin Cancer Res 2016 Dec 15;22(24):6061-6068 99 Citations |
| 1 | HER2 Status in Gastroesophageal Adenocarcinomas: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization Methodologies. (Robertson SA, Cimino-Mathews A, Cornish TC) Appl Immunohistochem Mol Morphol 2018 Jan;26(1):35-39 1 Citation |
| 1 | Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma. (Lyros O, Nie L, Moore T, Medda R, Otterson M, Behmaram B, Mackinnon A, Gockel I, Shaker R, Rafiee P) Mol Cancer Res 2016 Jul;14(7):647-59 11 Citations |
| 1 | Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K. (Yueh AE, Payne SN, Leystra AA, Van De Hey DR, Foley TM, Pasch CA, Clipson L, Matkowskyj KA, Deming DA) PLoS One 2016;11(2):e0148730 15 Citations |
| 1 | Metastatic Cancer to the Larynx: A Case Report and Update. (Zenga J, Mehrad M, Bradley JP) J Voice 2016 Nov;30(6):774.e9-774.e12 11 Citations |
| 1 | Next-Generation Sequencing of Matched Primary and Metastatic Rectal Adenocarcinomas Demonstrates Minimal Mutation Gain and Concordance to Colonic Adenocarcinomas. (Crumley SM, Pepper KL, Phan AT, Olsen RJ, Schwartz MR, Portier BP) Arch Pathol Lab Med 2016 Jun;140(6):529-35 16 Citations |
| 1 | High Rate of Positive Circumferential Resection Margins Following Rectal Cancer Surgery: A Call to Action. (Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH, Greene FL, Fleshman JW, Abbas MA, Peters W, Noyes K, Monson JR, Fleming FJ, Consortium for Optimizing the Treatment of Rectal Cancer (OSTRiCh)) Ann Surg 2015 Dec;262(6):891-8 127 Citations |
| 2 | Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. (Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA) Conn Med 2015 Aug;79(7):401-4 |
| 2 | Utility of dysphagia grade in predicting endoscopic ultrasound T-stage of non-metastatic esophageal cancer. (Fang TC, Oh YS, Szabo A, Khan A, Dua KS) Dis Esophagus 2016 Aug;29(6):642-8 14 Citations |
| 2 | Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. (Potkonjak M, Miura JT, Turaga KK, Johnston FM, Tsai S, Christians KK, Gamblin TC) HPB (Oxford) 2015 Dec;17(12):1119-23 12 Citations |
| 2 | Eliminating the Residual Negative Pressure in the Endoscopic Ultrasound Aspirating Needle Enhances Cytology Yield of Pancreas Masses. (Aadam AA, Oh YS, Shidham VB, Khan A, Hunt B, Rao N, Zhang Y, Tarima S, Dua KS) Dig Dis Sci 2016 Mar;61(3):890-9 13 Citations |
| 4 | Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic Signaling. (Roy I, McAllister DM, Gorse E, Dixon K, Piper CT, Zimmerman NP, Getschman AE, Tsai S, Engle DD, Evans DB, Volkman BF, Kalyanaraman B, Dwinell MB) Cancer Res 2015 Sep 01;75(17):3529-42 52 Citations |
| 2 | The Triple-Code Model for Pancreatic Cancer: Cross Talk Among Genetics, Epigenetics, and Nuclear Structure. (Lomberk GA, Urrutia R) Surg Clin North Am 2015 Oct;95(5):935-52 18 Citations |
| 2 | Wnt/β-Catenin Signaling Activation beyond Robust Nuclear β-Catenin Accumulation in Nondysplastic Barrett's Esophagus: Regulation via Dickkopf-1. (Lyros O, Rafiee P, Nie L, Medda R, Jovanovic N, Otterson MF, Behmaram B, Gockel I, Mackinnon A, Shaker R) Neoplasia 2015 Jul;17(7):598-611 16 Citations |
| 4 | Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. (Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S) HPB (Oxford) 2015 Oct;17(10):942-52 52 Citations |
| 1 | Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps. (Cobain EF, Chinnaiyan AM, Kurzrock R, Baker LH) JAMA Oncol 2015 Jul;1(4):542 1 Citation |
| 1 | Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408. (Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU) Int J Radiat Oncol Biol Phys 2015 Jul 15;92(4):863-73 27 Citations |
| 3 | Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma. (Samuels T, Hoekzema C, Gould J, Goldblatt M, Frelich M, Bosler M, Lee SH, Johnston N) Ann Otol Rhinol Laryngol 2015 Nov;124(11):893-902 15 Citations |
| 1 | PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. (Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, Biedrzycki B, Donehower RC, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Duffy SM, Goldberg RM, de la Chapelle A, Koshiji M, Bhaijee F, Huebner T, Hruban RH, Wood LD, Cuka N, Pardoll DM, Papadopoulos N, Kinzler KW, Zhou S, Cornish TC, Taube JM, Anders RA, Eshleman JR, Vogelstein B, Diaz LA Jr) N Engl J Med 2015 Jun 25;372(26):2509-20 7155 Citations |
| 2 | Oncocytic Adenocarcinoma of the Orbit. (Harris GJ, Paul S, Hunt BC) Ophthalmic Plast Reconstr Surg 2017;33(1):e18-e20 1 Citation |
| 1 | VEGF-A Expression Correlates with TP53 Mutations in Non-Small Cell Lung Cancer: Implications for Antiangiogenesis Therapy. (Schwaederlé M, Lazar V, Validire P, Hansson J, Lacroix L, Soria JC, Pawitan Y, Kurzrock R) Cancer Res 2015 Apr 01;75(7):1187-90 95 Citations |
| 1 | Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. (Chung TK, Van Hummelen P, Chan PK, Cheung TH, Yim SF, Yu MY, Ducar MD, Thorner AR, MacConaill LE, Doran G, Pedamallu CS, Ojesina AI, Wong RR, Wang VW, Freeman SS, Lau TS, Kwong J, Chan LK, Fromer M, May T, Worley MJ Jr, Esselen KM, Elias KM, Lawrence M, Getz G, Smith DI, Crum CP, Meyerson M, Berkowitz RS, Wong YF) Int J Cancer 2015 Aug 15;137(4):776-83 38 Citations |
| 2 | Neoadjuvant therapy for localized pancreatic cancer: support is growing? (Evans DB, Ritch PS, Erickson BA) Ann Surg 2015 Jan;261(1):18-20 18 Citations |
| 2 | Additional support for neoadjuvant therapy in the management of pancreatic cancer. (Christians KK, Evans DB) Ann Surg Oncol 2015 Jun;22(6):1755-8 5 Citations |
| 1 | The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. (Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V) Ann Surg Oncol 2016 Jan;23(1):290-6 81 Citations |
| 1 | Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer. (Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH) Ann Surg Oncol 2015 Jul;22(7):2416-23 124 Citations |
| 5 | Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer. (Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B) Radiother Oncol 2014 Oct;113(1):41-6 43 Citations |
| 1 | Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. (Hou MM, Liu X, Wheler J, Naing A, Hong D, Coleman RL, Tsimberidou A, Janku F, Zinner R, Lu K, Kurzrock R, Fu S) Oncotarget 2014 Nov 30;5(22):11168-79 52 Citations |
| 2 | Is local resection adequate for T1 stage ampullary cancer? (Amini A, Miura JT, Jayakrishnan TT, Johnston FM, Tsai S, Christians KK, Gamblin TC, Turaga KK) HPB (Oxford) 2015 Jan;17(1):66-71 31 Citations |
| 1 | Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma. (Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies SR, Ellis MJ, Visscher DW) Arch Pathol Lab Med 2014 Nov;138(11):1507-13 3 Citations |
| 1 | Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. (Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W) Int J Radiat Oncol Biol Phys 2014 Oct 01;90(2):320-8 155 Citations |
| 1 | Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. (Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC) Nat Commun 2014 Oct 03;5:5092 98 Citations |
| 1 | Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma. (West DL, White SB, Zhang Z, Larson AC, Omary RA) Int J Nanomedicine 2014;9:4169-76 16 Citations |
| 2 | Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2. (Nie L, Lyros O, Medda R, Jovanovic N, Schmidt JL, Otterson MF, Johnson CP, Behmaram B, Shaker R, Rafiee P) Am J Physiol Cell Physiol 2014 Nov 01;307(9):C859-77 46 Citations |
| 4 | Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater. (Miura JT, Jayakrishnan TT, Amini A, Johnston FM, Tsai S, Erickson B, Quebbeman EJ, Christians KK, Evans DB, Gamblin TC, Turaga KK) J Gastrointest Surg 2014 Nov;18(11):2003-8 12 Citations |
| 1 | Comprehensive molecular characterization of gastric adenocarcinoma. (Cancer Genome Atlas Research Network) Nature 2014 Sep 11;513(7517):202-9 4588 Citations |
| 4 | Molecular profiling in gastric cancer: examining potential targets for chemotherapy. (Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC) J Surg Oncol 2014 Sep;110(3):302-6 9 Citations |
| 7 | 3-T MRI-based adaptive brachytherapy for cervix cancer: treatment technique and initial clinical outcomes. (Kharofa J, Morrow N, Kelly T, Rownd J, Paulson E, Rader J, Uyar D, Bradley W, Erickson B) Brachytherapy 2014;13(4):319-25 28 Citations |
| 1 | Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer. (Kim ES, Tang X, Peterson DR, Kilari D, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Stewart DJ, Wistuba II, Siddik ZH) Lung Cancer 2014 Jul;85(1):88-93 64 Citations |
| 1 | MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit. (Jardim DL, de Melo Gagliato D, Falchook GS, Janku F, Zinner R, Wheler JJ, Subbiah V, Piha-Paul SA, Fu S, Murphy MB, Ajani J, Tang C, Hess K, Hamilton SR, Roy-Chowdhuri S, Kurzrock R, Meric-Bernstam F, Hong DS) Oncotarget 2014 Apr 15;5(7):1837-45 27 Citations |
| 1 | O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41. (Olivier-Van Stichelen S, Dehennaut V, Buzy A, Zachayus JL, Guinez C, Mir AM, El Yazidi-Belkoura I, Copin MC, Boureme D, Loyaux D, Ferrara P, Lefebvre T) FASEB J 2014 Aug;28(8):3325-38 113 Citations |
| 1 | A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in gene-targeted mice. (Cecchini MJ, Thwaites MJ, Talluri S, MacDonald JI, Passos DT, Chong JL, Cantalupo P, Stafford PM, Sáenz-Robles MT, Francis SM, Pipas JM, Leone G, Welch I, Dick FA) Mol Cell Biol 2014 Jun;34(11):2029-45 25 Citations |
| 6 | Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? (Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George B) Oncologist 2014 Mar;19(3):266-74 166 Citations |
| 1 | Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice. (Kim SJ, Amankwah E, Connors S, Park HY, Rincon M, Cornnell H, Chornokur G, Hashim AI, Choi J, Tsai YY, Engelman RW, Kumar N, Park JY) Cancer Prev Res (Phila) 2014 Apr;7(4):435-44 20 Citations |
| 1 | Landscape of genomic alterations in cervical carcinomas. (Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Treviño V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabiño NB, Gómez-Macías GS, Valdez-Chapa LD, Garza-Rodríguez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Saldaña HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M) Nature 2014 Feb 20;506(7488):371-5 649 Citations |
| 1 | Chemoradiation therapy sequencing for resected pancreatic adenocarcinoma in the National Cancer Data Base. (Colbert LE, Hall WA, Nickleach D, Switchenko J, Kooby DA, Liu Y, Gillespie T, Lipscomb J, Kauh J, Landry JC) Cancer 2014 Feb 15;120(4):499-506 39 Citations |
| 1 | Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. (Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD) Am J Obstet Gynecol 2014 Apr;210(4):366.e1-366.e5 25 Citations |
| 1 | Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis. (Porterfield M, Zhao P, Han H, Cunningham J, Aoki K, Von Hoff DD, Demeure MJ, Pierce JM, Tiemeyer M, Wells L) J Proteome Res 2014 Feb 07;13(2):395-407 30 Citations |
| 1 | Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer. (Hall WA, Petrova AV, Colbert LE, Hardy CW, Fisher SB, Saka B, Shelton JW, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Volkan Adsay N, Curran WJ, Landry JC, Maithel SK, Yu DS) Oncogene 2014 Nov 20;33(47):5450-6 18 Citations |
| 1 | Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. (Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH) J Gastrointest Surg 2014 Jan;18(1):16-24; discussion 24-5 163 Citations |
| 1 | Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. (Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH) J Gastrointest Surg 2014 Feb;18(2):269-78; discussion 278 96 Citations |
| 1 | Single-cell analysis reveals early manifestation of cancerous phenotype in pre-malignant esophageal cells. (Wang J, Shi X, Johnson RH, Kelbauskas L, Zhang W, Meldrum DR) PLoS One 2013;8(10):e75365 135 Citations |
| 2 | Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis. (Cano CE, Hamidi T, Garcia MN, Grasso D, Loncle C, Garcia S, Calvo E, Lomberk G, Dusetti N, Bartholin L, Urrutia R, Iovanna JL) Gut 2014 Jun;63(6):984-95 34 Citations |
| 2 | Borderline resectable/locally advanced pancreatic adenocarcinoma: improvements needed in population-based registries. (Miura JT, Evans DB, Pappas SG, Gamblin TC, Turaga KK) Ann Surg Oncol 2013 Dec;20(13):4338-47 7 Citations |
| 1 | MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. (Meng W, Ye Z, Cui R, Perry J, Dedousi-Huebner V, Huebner A, Wang Y, Li B, Volinia S, Nakanishi H, Kim T, Suh SS, Ayers LW, Ross P, Croce CM, Chakravarti A, Jin VX, Lautenschlaeger T) Clin Cancer Res 2013 Oct 01;19(19):5423-33 96 Citations |
| 1 | Rational study endpoint(s) for preoperative trials in pancreatic cancer: pathologic response rate, margin negative resection, overall survival or 'all of the above'? (Varadhachary GR, Evans DB) Ann Surg Oncol 2013 Nov;20(12):3712-4 5 Citations |
| 1 | Endometrial echo complex thickness in postmenopausal endometrial cancer. (Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L) Gynecol Oncol 2013 Oct;131(1):109-12 13 Citations |
| 1 | Repeat liver resection after a hepatic or extended hepatic trisectionectomy for colorectal liver metastasis. (Ziff O, Rajput I, Adair R, Toogood GJ, Prasad KR, Lodge JP) HPB (Oxford) 2014 Mar;16(3):212-9 8 Citations |
| 1 | TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. (Schabath MB, Giuliano AR, Thompson ZJ, Amankwah EK, Gray JE, Fenstermacher DA, Jonathan KA, Beg AA, Haura EB) Carcinogenesis 2013 Nov;34(11):2525-30 17 Citations |
| 1 | The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate. (Hall WA, Nickleach DC, Master VA, Prabhu RS, Rossi PJ, Godette K, Cooper S, Jani AB) Cancer 2013 Sep 15;119(18):3272-9 33 Citations |
| 1 | Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients. (Schmidt B, Look-Hong N, Maduekwe UN, Chang K, Hong TS, Kwak EL, Lauwers GY, Rattner DW, Mullen JT, Yoon SS) Ann Surg Oncol 2013 Oct;20(11):3512-8 29 Citations |
| 1 | D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging. (Schmidt B, Chang KK, Maduekwe UN, Look-Hong N, Rattner DW, Lauwers GY, Mullen JT, Yang HK, Yoon SS) Ann Surg Oncol 2013 Sep;20(9):2991-9 21 Citations |
| 1 | Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma. (Colbert LE, Fisher SB, Hardy CW, Hall WA, Saka B, Shelton JW, Petrova AV, Warren MD, Pantazides BG, Gandhi K, Kowalski J, Kooby DA, El-Rayes BF, Staley CA 3rd, Adsay NV, Curran WJ Jr, Landry JC, Maithel SK, Yu DS) Cancer 2013 Sep 01;119(17):3148-55 99 Citations |
| 1 | Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort. (Gaddam S, Singh M, Balasubramanian G, Thota P, Gupta N, Wani S, Higbee AD, Mathur SC, Horwhat JD, Rastogi A, Young PE, Cash BD, Bansal A, Vargo JJ, Falk GW, Lieberman DA, Sampliner RE, Sharma P) Gastroenterology 2013 Sep;145(3):548-53.e1 72 Citations |
| 1 | The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. (Hall WA, Colbert LE, Liu Y, Gillespie T, Lipscomb J, Hardy C, Kooby DA, Prabhu RS, Kauh J, Landry JC) Cancer 2013 Jun 15;119(12):2350-7 11 Citations |
| 1 | Brain metastasis from oesophageal adenocarcinoma. (Nwankwo N, Mirrakhimov AE, Wind KP, Bucher N) BMJ Case Rep 2013 Apr 19;2013 1 Citation |
| 1 | Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis. (Gounaris E, Martin J, Ishihara Y, Khan MW, Lee G, Sinh P, Chen EZ, Angarone M, Weissleder R, Khazaie K, Barrett TA) Inflamm Bowel Dis 2013 Jun;19(7):1339-45 38 Citations |
| 5 | Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility? (Pappas SG, Christians KK, Tolat PP, Mautz AP, Lal A, McElroy L, Gamblin TC, Turaga KK, Tsai S, Erickson B, Ritch P, Evans DB) HPB (Oxford) 2014 Jan;16(1):70-4 23 Citations |
| 1 | Right hemicolectomy for mucinous adenocarcinoma of the appendix: just right or too much? (Turaga KK, Pappas S, Gamblin TC) Ann Surg Oncol 2013 Apr;20(4):1063-7 50 Citations |
| 1 | Clinical utility and interobserver agreement of autofluorescence imaging and magnification narrow-band imaging for the evaluation of Barrett's esophagus: a prospective tandem study. (Giacchino M, Bansal A, Kim RE, Singh V, Hall SB, Singh M, Rastogi A, Moloney B, Wani SB, Gaddam S, Mathur SC, Wallace MB, Kanakadandi V, Balasubramanian G, Gupta N, Sharma P) Gastrointest Endosc 2013 May;77(5):711-8 31 Citations |
| 1 | The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. (Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB) Ann Surg Oncol 2013 Dec;20 Suppl 3:S500-8 57 Citations |
| 1 | Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatment. (Falchook GS, Janku F, Tsao AS, Bastida CC, Stewart DJ, Kurzrock R) J Thorac Oncol 2013 Feb;8(2):e19-20 24 Citations |
| 1 | Do older Americans undergo stoma reversal following low anterior resection for rectal cancer? (Dodgion CM, Neville BA, Lipsitz SR, Hu YY, Schrag D, Breen E, Greenberg CC) J Surg Res 2013 Jul;183(1):238-45 24 Citations |
| 1 | Tumor size on abdominal MRI versus pathologic specimen in resected pancreatic adenocarcinoma: implications for radiation treatment planning. (Hall WA, Mikell JL, Mittal P, Colbert L, Prabhu RS, Kooby DA, Nickleach D, Hanley K, Sarmiento JM, Ali AN, Landry JC) Int J Radiat Oncol Biol Phys 2013 May 01;86(1):102-7 31 Citations |
| 1 | Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. (Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, Hosgood HD 3rd, Chen K, Wang JC, Chatterjee N, Hu W, Wong MP, Zheng W, Caporaso N, Park JY, Chen CJ, Kim YH, Kim YT, Landi MT, Shen H, Lawrence C, Burdett L, Yeager M, Yuenger J, Jacobs KB, Chang IS, Mitsudomi T, Kim HN, Chang GC, Bassig BA, Tucker M, Wei F, Yin Z, Wu C, An SJ, Qian B, Lee VH, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Kim JH, Gao YT, Tsai YH, Jung YJ, Guo H, Hu Z, Hutchinson A, Wang WC, Klein R, Chung CC, Oh IJ, Chen KY, Berndt SI, He X, Wu W, Chang J, Zhang XC, Huang MS, Zheng H, Wang J, Zhao X, Li Y, Choi JE, Su WC, Park KH, Sung SW, Shu XO, Chen YM, Liu L, Kang CH, Hu L, Chen CH, Pao W, Kim YC, Yang TY, Xu J, Guan P, Tan W, Su J, Wang CL, Li H, Sihoe AD, Zhao Z, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Kohno T, Kweon SS, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chow WH, Ji BT, Chan JK, Chu M, Li YJ, Yokota J, Li J, Chen H, Xiang YB, Yu CJ, Kunitoh H, Wu G, Jin L, Lo YL, Shiraishi K, Chen YH, Lin HC, Wu T, Wu YL, Yang PC, Zhou B, Shin MH, Fraumeni JF Jr, Lin D, Chanock SJ, Rothman N) Nat Genet 2012 Dec;44(12):1330-5 261 Citations |
| 1 | Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer. (Havlik R, Srovnal J, Klos D, Benedikova A, Lovecek M, Ghothim M, Cahova D, Neoral C, Hajduch M) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013 Sep;157(3):233-8 7 Citations |
| 1 | Gastric cardia cancer: how much is it from fat? (Sinh P, Sharma P) Dig Dis Sci 2012 Oct;57(10):2493-6 3 Citations |
| 2 | Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death. (Hamidi T, Cano CE, Grasso D, Garcia MN, Sandi MJ, Calvo EL, Dagorn JC, Lomberk G, Urrutia R, Goruppi S, Carracedo A, Velasco G, Iovanna JL) Clin Cancer Res 2012 Oct 01;18(19):5234-46 61 Citations |
| 2 | Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer. (Cano CE, Sandí MJ, Hamidi T, Calvo EL, Turrini O, Bartholin L, Loncle C, Secq V, Garcia S, Lomberk G, Kroemer G, Urrutia R, Iovanna JL) EMBO Mol Med 2012 Sep;4(9):964-79 63 Citations |
| 3 | Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma. (Christians KK, Tsai S, Tolat PP, Evans DB) J Surg Oncol 2013 Jan;107(1):33-8 37 Citations |
| 2 | Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. (Hamidi T, Algül H, Cano CE, Sandi MJ, Molejon MI, Riemann M, Calvo EL, Lomberk G, Dagorn JC, Weih F, Urrutia R, Schmid RM, Iovanna JL) J Clin Invest 2012 Jun;122(6):2092-103 102 Citations |
| 1 | Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. (Aadam AA, Evans DB, Khan A, Oh Y, Dua K) Gastrointest Endosc 2012 Jul;76(1):67-75 86 Citations |
| 1 | Vascular invasion in pancreatic cancer: predictive values for endoscopic ultrasound and computed tomography imaging. (Tellez-Avila FI, Chavez-Tapia NC, López-Arce G, Franco-Guzmán AM, Sosa-Lozano LA, Alfaro-Lara R, Chan-Nuñez C, Giovannini M, Elizondo-Rivera J, Ramírez-Luna MA) Pancreas 2012 May;41(4):636-8 30 Citations |
| 1 | Aerosolized 3-bromopyruvate inhibits lung tumorigenesis without causing liver toxicity. (Zhang Q, Pan J, North PE, Yang S, Lubet RA, Wang Y, You M) Cancer Prev Res (Phila) 2012 May;5(5):717-25 35 Citations |
| 1 | Ex vivo evaluation of preoperatively treated rectal cancer specimens of patients undergoing radical resection. (de la Fuente SG, Ludwig KA, Tyler DS, Mantyh CR) Ann Surg Oncol 2012 Jun;19(6):1954-8 2 Citations |
| 1 | Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. (Lawton CA, Yan Y, Lee WR, Gillin M, Firat S, Baikadi M, Crook J, Kuettel M, Morton G, Sandler H) Int J Radiat Oncol Biol Phys 2012 Apr 01;82(5):e795-801 49 Citations |
| 1 | Importance of histologic subtype in the staging of appendiceal tumors. (Turaga KK, Pappas SG, Gamblin T) Ann Surg Oncol 2012 May;19(5):1379-85 148 Citations |
| 1 | The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. (Viswanathan AN, Moughan J, Small W Jr, Levenback C, Iyer R, Hymes S, Dicker AP, Miller B, Erickson B, Gaffney DK) Int J Gynecol Cancer 2012 Jan;22(1):123-31 101 Citations |
| 1 | Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. (Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H) Cancer 2012 Aug 01;118(15):3801-11 58 Citations |
| 1 | A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. (Fox EM, Miller TW, Balko JM, Kuba MG, Sánchez V, Smith RA, Liu S, González-Angulo AM, Mills GB, Ye F, Shyr Y, Manning HC, Buck E, Arteaga CL) Cancer Res 2011 Nov 01;71(21):6773-84 132 Citations |
| 1 | Validation of the Royal Marsden Hospital prognostic score in patients treated in the Phase I Clinical Trials Program at the MD Anderson Cancer Center. (Garrido-Laguna I, Janku F, Vaklavas C, Falchook GS, Fu S, Hong DS, Naing A, Tsimberidou AM, Wen S, Kurzrock R) Cancer 2012 Mar 01;118(5):1422-8 79 Citations |
| 1 | BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro. (Li W, Li B, Giacalone NJ, Torossian A, Sun Y, Niu K, Lin-Tsai O, Lu B) J Thorac Oncol 2011 Nov;6(11):1801-9 |
| 1 | Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. (Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H) Cancer 2012 Jan 01;118(1):268-77 72 Citations |
| 1 | Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial. (Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW) Ann Surg Oncol 2011 Dec;18(13):3615-22 18 Citations |
| 1 | ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. (Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, Kopetz S, McConkey DJ, Evans DB, Gallick GE) PLoS One 2011;6(6):e20636 228 Citations |
| 1 | Major determinants of photoinduced cell death: Subcellular localization versus photosensitization efficiency. (Oliveira CS, Turchiello R, Kowaltowski AJ, Indig GL, Baptista MS) Free Radic Biol Med 2011 Aug 15;51(4):824-33 148 Citations |
| 1 | [Signaling and metabolic predispositions linked to the colorectal cancer]. (Olivier S, Mir AM, Michalski JC, Lefebvre T) Med Sci (Paris) 2011 May;27(5):514-20 2 Citations |
| 2 | Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study. (Kiefer MV, Albert M, McNally M, Robertson M, Sun W, Fraker D, Olthoff K, Christians K, Pappas S, Rilling W, Soulen MC) Cancer 2011 Apr 01;117(7):1498-505 126 Citations |
| 1 | An evidence-based review of the surgical treatment of gastric adenocarcinoma. (Maduekwe UN, Yoon SS) J Gastrointest Surg 2011 May;15(5):730-41 9 Citations |
| 1 | Potent antitumor and antineoplastic efficacy of baicalein on benzo(a)pyrene-induced experimental pulmonary tumorigenesis. (Naveenkumar C, Asokkumar S, Raghunandhakumar S, Jagan S, Anandakumar P, Augustine TA, Kamaraj S, Devaki T) Fundam Clin Pharmacol 2012 Apr;26(2):259-70 24 Citations |
| 1 | MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese. (Dong J, Ren B, Hu Z, Chen J, Hu L, Dai J, Jin G, Xu L, Shen H) Mol Carcinog 2011 Jun;50(6):433-8 19 Citations |
| 2 | Fetal lung interstitial tumor (FLIT): A proposed newly recognized lung tumor of infancy to be differentiated from cystic pleuropulmonary blastoma and other developmental pulmonary lesions. (Dishop MK, McKay EM, Kreiger PA, Priest JR, Williams GM, Langston C, Jarzembowski J, Suchi M, Dehner LP, Hill DA) Am J Surg Pathol 2010 Dec;34(12):1762-72 57 Citations |
| 1 | Double-balloon enteroscopy enabled the diagnosis of duodenal adenocarcinoma in a patient with Roux-en-Y gastric bypass surgery presenting with chronic anemia. (Sourianarayanane A, Mukewar SS, Upchurch BR, Bauer TW, Sanaka MR) Gastrointest Endosc 2011 Apr;73(4):837-8 3 Citations |
| 1 | Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor. (Yu N, Kozlowski JM, Park II, Chen L, Zhang Q, Xu D, Doll JA, Crawford SE, Brendler CB, Lee C) Urology 2010 Dec;76(6):1519.e8-13 28 Citations |
| 1 | Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. (Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman LD, Cliby WA) Obstet Gynecol 2010 Nov;116(5):1150-7 41 Citations |
| 1 | Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. (Song X, Wang H, Logsdon CD, Rashid A, Fleming JB, Abbruzzese JL, Gomez HF, Evans DB, Wang H) Cancer 2011 Feb 15;117(4):734-43 118 Citations |
| 1 | Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival. (Dai J, Jin G, Dong J, Chen Y, Xu L, Hu Z, Shen H) J Thorac Oncol 2010 Nov;5(11):1748-54 |
| 2 | Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. (Evans DB, Erickson BA, Ritch P) Ann Surg Oncol 2010 Nov;17(11):2803-5 58 Citations |
| 1 | Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. (Rizvi S, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernández-Zapico ME, Buttar NS) Cancer Res 2010 Sep 01;70(17):6787-96 41 Citations |
| 1 | Adult-onset hypogonadotropic hypogonadism caused by aberrant expression of aromatase in an adrenocortical adenocarcinoma. (Advani A, Johnson SJ, Nicol MR, Papacleovoulou G, Evans DB, Vaikkakara S, Mason JI, Quinton R) Endocr J 2010;57(7):651-6 6 Citations |
| 1 | Angiogenesis. (Lomberk G) Pancreatology 2010;10(2-3):112-3 2 Citations |
| 1 | Chemotherapy resistance and retreatment: a dogma revisited. (Naing A, Kurzrock R) Clin Colorectal Cancer 2010 Apr;9(2):E1-4 |
| 2 | Portal vein resection. (Christians KK, Lal A, Pappas S, Quebbeman E, Evans DB) Surg Clin North Am 2010 Apr;90(2):309-22 39 Citations |
| 1 | Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. (Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB) Ann Surg Oncol 2010 Jul;17(7):1794-801 133 Citations |
| 2 | Management of borderline resectable pancreatic cancer. (Lal A, Christians K, Evans DB) Surg Oncol Clin N Am 2010 Apr;19(2):359-70 9 Citations |
| 1 | Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. (Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG) Cancer 2010 Apr 01;116(7):1656-63 15 Citations |
| 1 | New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. (Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS) Ann Surg Oncol 2010 May;17(5):1267-77 54 Citations |
| 1 | 18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer. (Showalter TN, Miller TR, Huettner P, Rader J, Grigsby PW) Int J Gynecol Cancer 2009 Nov;19(8):1412-4 32 Citations |
| 1 | Limitations of the SEER database for demonstrating causal relationships between treatments and outcomes in pediatric intestinal tumors. (Lal A, Lal DR) J Surg Res 2010 Jun 15;161(2):237-9 5 Citations |
| 1 | Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. (Reyes-Gibby CC, Shete S, Yennurajalingam S, Frazier M, Bruera E, Kurzrock R, Crane CH, Abbruzzese J, Evans D, Spitz MR) J Pain Symptom Manage 2009 Dec;38(6):894-902 38 Citations |
| 1 | Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas. (Saif MW, Oettle H, Vervenne WL, Thomas JP, Spitzer G, Visseren-Grul C, Enas N, Richards DA) Cancer J 2009;15(4):339-43 43 Citations |
| 1 | Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. (Halberg RB, Waggoner J, Rasmussen K, White A, Clipson L, Prunuske AJ, Bacher JW, Sullivan R, Washington MK, Pitot HC, Petrini JH, Albertson DG, Dove WF) Cancer Res 2009 Jul 15;69(14):5768-75 35 Citations |
| 1 | Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake. (Kidd EA, Spencer CR, Huettner PC, Siegel BA, Dehdashti F, Rader JS, Grigsby PW) Cancer 2009 Aug 01;115(15):3548-54 70 Citations |
| 1 | CD83 polymorphisms and cervical cancer risk. (Yu KJ, Rader JS, Borecki I, Zhang Z, Hildesheim A) Gynecol Oncol 2009 Aug;114(2):319-22 19 Citations |
| 1 | Cardiac arrest during laparotomy with argon beam coagulation of metastatic ovarian cancer. (Kizer N, Zighelboim I, Rader JS) Int J Gynecol Cancer 2009 Feb;19(2):237-8 3 Citations |
| 1 | Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study. (Fortune BE, Li X, Kosuri KV, Weatherby LM, Thomas JP, Bekaii-Saab TS) Oncology 2009;76(5):333-7 21 Citations |
| 1 | Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. (Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB) Arch Surg 2009 Mar;144(3):216-21 89 Citations |
| 1 | Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer. (Dong X, Jiao L, Li Y, Evans DB, Wang H, Hess KR, Abbruzzese JL, Li D) J Clin Oncol 2009 Apr 01;27(10):1592-9 43 Citations |
| 1 | Recutting prostate needle core biopsies with high grade prostatic intraepithelial neoplasia increases detection of adenocarcinoma. (Rapp DE, Msezane LP, Reynolds WS, Lotan TL, Obara P, O'Connor RC, Taxy JB, Gerber GS, Zagaja GP) Can J Urol 2009 Feb;16(1):4484-9 5 Citations |
| 1 | Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. (Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2009 Apr;16(4):836-47 415 Citations |
| 1 | Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. (Chen J, Li D, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Ann Surg Oncol 2009 Feb;16(2):431-9 44 Citations |
| 1 | Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. (Liang JJ, Wang H, Rashid A, Tan TH, Hwang RF, Hamilton SR, Abbruzzese JL, Evans DB, Wang H) Clin Cancer Res 2008 Nov 01;14(21):7043-9 90 Citations |
| 1 | Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. (de la Fuente SG, Manson RJ, Ludwig KA, Mantyh CR) J Gastrointest Surg 2009 Feb;13(2):269-74 55 Citations |
| 1 | Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. (Chen J, Killary AM, Sen S, Amos CI, Evans DB, Abbruzzese JL, Frazier ML) Cancer Lett 2008 Dec 08;272(1):32-9 11 Citations |
| 1 | Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. (Ghosh K, Thodeti CK, Dudley AC, Mammoto A, Klagsbrun M, Ingber DE) Proc Natl Acad Sci U S A 2008 Aug 12;105(32):11305-10 175 Citations |
| 1 | Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. (Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB) J Clin Oncol 2008 Jul 20;26(21):3487-95 415 Citations |
| 1 | Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. (Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA) J Clin Oncol 2008 Jul 20;26(21):3496-502 658 Citations |
| 1 | Phase II trial of curcumin in patients with advanced pancreatic cancer. (Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R) Clin Cancer Res 2008 Jul 15;14(14):4491-9 1168 Citations |
| 1 | Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. (Wolff RA, Varadhachary GR, Evans DB) Ann Surg Oncol 2008 Oct;15(10):2773-86 51 Citations |
| 1 | Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. (Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C, Hicks JL, Morgan J, Cornish TC, Sutcliffe S, Isaacs WB, Luo J, De Marzo AM) Mod Pathol 2008 Sep;21(9):1156-67 326 Citations |
| 2 | Expression and function of fatty acid amide hydrolase in prostate cancer. (Endsley MP, Thill R, Choudhry I, Williams CL, Kajdacsy-Balla A, Campbell WB, Nithipatikom K) Int J Cancer 2008 Sep 15;123(6):1318-26 82 Citations |
| 1 | Epidermal growth factor promotes breast cancer cell chemotaxis in CXCL12 gradients. (Mosadegh B, Saadi W, Wang SJ, Jeon NL) Biotechnol Bioeng 2008 Aug 15;100(6):1205-13 62 Citations |
| 1 | Transabdominal preperitoneal robotic inguinal hernia repair. (Ito F, Jarrard D, Gould JC) J Laparoendosc Adv Surg Tech A 2008 Jun;18(3):397-9 20 Citations |
| 1 | Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. (Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF) J Am Coll Surg 2008 May;206(5):833-46; discussion 846-8 691 Citations |
| 1 | Tumor-node-metastasis staging of pancreatic adenocarcinoma. (Katz MH, Hwang R, Fleming JB, Evans DB) CA Cancer J Clin 2008;58(2):111-25 101 Citations |
| 1 | Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. (Hwang RF, Wang H, Lara A, Gomez H, Chang T, Sieffert N, Moon Y, Ram S, Zimmerman S, Lee JH, Pisters PW, Tamm EP, Fleming JB, Abbruzzese JL, Evans DB) Ann Surg Oncol 2008 May;15(5):1356-66 55 Citations |
| 1 | Cancer-associated stromal fibroblasts promote pancreatic tumor progression. (Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD) Cancer Res 2008 Feb 01;68(3):918-26 911 Citations |
| 1 | CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. (Zhang Z, Borecki I, Nguyen L, Ma D, Smith K, Huettner PC, Mutch DG, Herzog TJ, Gibb RK, Powell MA, Grigsby PW, Massad LS, Hernandez E, Judson PL, Swisher EM, Crowder S, Li J, Gerhard DS, Rader JS) Cancer Res 2007 Dec 01;67(23):11202-8 30 Citations |
| 1 | Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas. (Gamblin TC, Egorin MJ, Zuhowski EG, Lagattuta TF, Herscher LL, Russo A, Libutti SK, Alexander HR, Dedrick RL, Bartlett DL) Cancer Chemother Pharmacol 2008 Sep;62(4):647-53 17 Citations |
| 1 | Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome. (Hamady ZZ, Malik HZ, Alwan N, Wyatt JI, Prasad KR, Toogood GJ, Lodge JP) Eur J Surg Oncol 2008 Feb;34(2):180-4 5 Citations |
| 1 | Colonic adenocarcinoma in a 13-year-old with cystic fibrosis. (Ibele AR, Koplin SA, Slaughenhoupt BL, Kryger JV, Friedl A, Lund DP) J Pediatr Surg 2007 Oct;42(10):E1-3 12 Citations |
| 1 | Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data. (Hazard L, Tward JD, Szabo A, Shrieve DC) Cancer 2007 Nov 15;110(10):2191-201 70 Citations |
| 1 | Clinical benefit of palliative radiation therapy in advanced gastric cancer. (Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, Mansfield PF, Ajani JA, Crane CH, Krishnan S) Acta Oncol 2008;47(3):421-7 82 Citations |
| 1 | Evaluation of candidate methylation markers to detect cervical neoplasia. (Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS) Gynecol Oncol 2007 Dec;107(3):549-53 57 Citations |
| 1 | Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Tward JD, Skidmore TB, Gaffney DK) Cancer 2007 Nov 01;110(9):2092-100 29 Citations |
| 1 | Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. (Cheng YY, Yu J, Wong YP, Man EP, To KF, Jin VX, Li J, Tao Q, Sung JJ, Chan FK, Leung WK) Br J Cancer 2007 Oct 08;97(7):895-901 116 Citations |
| 1 | Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. (Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB) Ann Surg 2007 Jul;246(1):52-60 503 Citations |
| 1 | Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid. (Ryan CW, Huo D, Bylow K, Demers LM, Stadler WM, Henderson TO, Vogelzang NJ) BJU Int 2007 Jul;100(1):70-5 50 Citations |
| 1 | Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. (Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D) Cancer 2007 Jun 15;109(12):2547-56 47 Citations |
| 1 | Rectourethral fistula after combination radiotherapy for prostate cancer. (Marguet C, Raj GV, Brashears JH, Anscher MS, Ludwig K, Mouraviev V, Robertson CN, Polascik TJ) Urology 2007 May;69(5):898-901 43 Citations |
| 1 | Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. (Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK) Nat Clin Pract Oncol 2007 May;4(5):316-21 50 Citations |
| 1 | Arterial variants in pancreatic adenocarcinoma. (Balachandran A, Darden DL, Tamm EP, Faria SC, Evans DB, Charnsangavej C) Abdom Imaging 2008;33(2):214-21 35 Citations |
| 1 | Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death. (Uwagawa T, Li Z, Chang Z, Xia Q, Peng B, Sclabas GM, Ishiyama S, Hung MC, Evans DB, Abbruzzese JL, Chiao PJ) Cancer 2007 May 15;109(10):2142-53 42 Citations |
| 1 | Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. (Small W Jr, Winter K, Levenback C, Iyer R, Gaffney D, Asbell S, Erickson B, Jhingran A, Greven K) Int J Radiat Oncol Biol Phys 2007 Jul 15;68(4):1081-7 122 Citations |
| 1 | Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? (Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW) J Am Coll Surg 2007 Mar;204(3):347-55 112 Citations |
| 1 | Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. (Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S) Diagn Cytopathol 2007 Mar;35(3):143-7 23 Citations |
| 1 | Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. (Liang H, Wu H, Giorgadze TA, Sariya D, Bellucci KS, Veerappan R, Liegl B, Acs G, Elenitsas R, Shukla S, Youngberg GA, Coogan PS, Pasha T, Zhang PJ, Xu X) Am J Surg Pathol 2007 Feb;31(2):304-10 78 Citations |
| 1 | K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. (Jiao L, Zhu J, Hassan MM, Evans DB, Abbruzzese JL, Li D) Pancreas 2007 Jan;34(1):55-62 74 Citations |
| 1 | Stents for palliating malignant dysphagia and fistula: is the paradigm shifting? (Dua KS) Gastrointest Endosc 2007 Jan;65(1):77-81 38 Citations |
| 1 | Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. (Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH) Cancer 2006 Dec 01;107(11):2589-96 76 Citations |
| 1 | Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis. (Tward JD, Lee CM, Pappas LM, Szabo A, Gaffney DK, Shrieve DC) Cancer 2006 Nov 15;107(10):2392-400 57 Citations |
| 1 | Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. (Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX) Cancer Res 2006 Sep 01;66(17):8581-9 55 Citations |
| 1 | Src activation of Stat3 is an independent requirement from NF-kappaB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells. (Trevino JG, Gray MJ, Nawrocki ST, Summy JM, Lesslie DP, Evans DB, Sawyer TK, Shakespeare WC, Watowich SS, Chiao PJ, McConkey DJ, Gallick GE) Angiogenesis 2006;9(2):101-10 42 Citations |
| 1 | Microdissection-based allelotyping: a novel technique to determine the temporal sequence and biological aggressiveness of colorectal cancer. (Gamblin TC, Finkelstein SD, Upsal N, Kaye JD, Blumberg D) Am Surg 2006 May;72(5):445-53 6 Citations |
| 1 | Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer. (Zhang Z, Huettner PC, Nguyen L, Bidder M, Funk MC, Li J, Rader JS) Oncogene 2006 Aug 31;25(39):5436-45 34 Citations |
| 1 | Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. (Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF) Endocr Relat Cancer 2006 Mar;13(1):151-67 124 Citations |
| 1 | Reversible posterior leukoencephalopathy syndrome and bevacizumab. (Ozcan C, Wong SJ, Hari P) N Engl J Med 2006 Mar 02;354(9):980-2; discussion 980-2 |
| 1 | Metastatic colon cancer to the hand. (Gamblin TC, Santos RS, Baratz M, Landreneau RJ) Am Surg 2006 Jan;72(1):98-100 11 Citations |
| 1 | The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. (Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D) Cancer Lett 2007 Jan 08;245(1-2):61-8 50 Citations |
| 1 | Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. (Czito BG, Willett CG, Bendell JC, Morse MA, Tyler DS, Fernando NH, Mantyh CR, Blobe GC, Honeycutt W, Yu D, Clary BM, Pappas TN, Ludwig KA, Hurwitz HI) J Clin Oncol 2006 Feb 01;24(4):656-62 130 Citations |
| 1 | Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma. (Ajani JA, Lee FC, Singh DA, Haller DG, Lenz HJ, Benson AB 3rd, Yanagihara R, Phan AT, Yao JC, Strumberg D) J Clin Oncol 2006 Feb 01;24(4):663-7 93 Citations |
| 1 | Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. (Lee CM, Szabo A, Shrieve DC, Macdonald OK, Gaffney DK) JAMA 2006 Jan 25;295(4):389-97 113 Citations |
| 1 | From cystic pulmonary airway malformation, to bronchioloalveolar carcinoma and adenocarcinoma of the lung. (Ioachimescu OC, Mehta AC) Eur Respir J 2005 Dec;26(6):1181-7 87 Citations |
| 1 | A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. (Lee WR, DeSilvio M, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Int J Radiat Oncol Biol Phys 2006 Mar 01;64(3):804-9 34 Citations |
| 1 | A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma. (Morgan-Meadows S, Mulkerin D, Berlin JD, Kim K, Bailey H, Saphner T, Jumonville A, Hansen R, Ahuja H, McFarland T, Thomas JP) Oncology 2005;69(2):130-4 15 Citations |
| 2 | Endoscopic management of sinonasal tumors: a preliminary report. (Poetker DM, Toohill RJ, Loehrl TA, Smith TL) Am J Rhinol 2005;19(3):307-15 63 Citations |
| 1 | Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells. (Li A, Felix JC, Minoo P, Amezcua CA, Jain JK) Fertil Steril 2005 Jul;84(1):202-11 38 Citations |
| 1 | Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. (Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM) Carcinogenesis 2006 Jan;27(1):103-11 88 Citations |
| 1 | Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. (Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW) Arch Surg 2005 Jun;140(6):584-9; discussion 589-91 94 Citations |
| 1 | 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. (Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, Lenzi R, Evans DB, Bondy ML, Pisters PW, Abbruzzese JL, Hassan MM) Cancer Epidemiol Biomarkers Prev 2005 Jun;14(6):1470-6 62 Citations |
| 1 | Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas. (Wong AA, Delclos ME, Wolff RA, Evans DB, Abbruzzese JL, Tamm EP, Xiong HQ, Ho L, Crane CH, Pancreatic Tumor Study Group) Am J Clin Oncol 2005 Jun;28(3):227-33 13 Citations |
| 1 | Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. (Gray MJ, Wey JS, Belcheva A, McCarty MF, Trevino JG, Evans DB, Ellis LM, Gallick GE) Cancer Res 2005 May 01;65(9):3664-70 82 Citations |
| 1 | Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin. (Sclabas GM, Uwagawa T, Schmidt C, Hess KR, Evans DB, Abbruzzese JL, Chiao PJ) Cancer 2005 Jun 15;103(12):2485-90 67 Citations |
| 1 | Combined-modality treatment for operable pancreatic adenocarcinoma. (Pisters PW, Wolff RA, Crane CH, Evans DB) Oncology (Williston Park) 2005 Mar;19(3):393-404, 409; discussion 409-10, 412-6 24 Citations |
| 1 | Primary epithelial lung malignancies in the pediatric population. (Lal DR, Clark I, Shalkow J, Downey RJ, Shorter NA, Klimstra DS, La Quaglia MP) Pediatr Blood Cancer 2005 Oct 15;45(5):683-6 51 Citations |
| 1 | Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. (Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, Yang W, Yokoi K, Evans DB, Abbruzzese JL, Hess KR, Zhang W, Fidler IJ, Chiao PJ) Clin Cancer Res 2005 Jan 15;11(2 Pt 1):440-9 120 Citations |
| 1 | Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. (Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS) Genes Chromosomes Cancer 2005 May;43(1):95-103 14 Citations |
| 1 | Lack of benefit of concurrent chemotherapy in patients with cervical cancer and negative lymph nodes by FDG-PET. (Grigsby PW, Mutch DG, Rader J, Herzog TJ, Zoberi I, Siegel BA, Dehdashti F) Int J Radiat Oncol Biol Phys 2005 Feb 01;61(2):444-9 30 Citations |
| 1 | Pancreaticoduodenectomy with vascular resection: margin status and survival duration. (Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB) J Gastrointest Surg 2004 Dec;8(8):935-49; discussion 949-50 494 Citations |
| 1 | Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. (Eifel PJ, Moughan J, Erickson B, Iarocci T, Grant D, Owen J) Int J Radiat Oncol Biol Phys 2004 Nov 15;60(4):1144-53 118 Citations |
| 1 | Expression and localization of GRP75 in human epithelial tumors and normal tissues. (Srokowski T, Pfeifer JD, Li J, Olson LM, Rader JS) Appl Immunohistochem Mol Morphol 2004 Jun;12(2):132-8 7 Citations |
| 1 | Neoadjuvant therapy for resectable pancreatic cancer. (Raut CP, Evans DB, Crane CH, Pisters PW, Wolff RA) Surg Oncol Clin N Am 2004 Oct;13(4):639-61, ix 53 Citations |
| 1 | Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium. (Schlicht M, Matysiak B, Brodzeller T, Wen X, Liu H, Zhou G, Dhir R, Hessner MJ, Tonellato P, Suckow M, Pollard M, Datta MW) BMC Genomics 2004 Aug 20;5(1):58 27 Citations |
| 1 | Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. (Halin S, Wikström P, Rudolfsson SH, Stattin P, Doll JA, Crawford SE, Bergh A) Cancer Res 2004 Aug 15;64(16):5664-71 78 Citations |
| 1 | Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms. (Wright JD, Powell MA, Herzog TJ, Mutch DG, Rader JS, Gao F, Gibb RK) Gynecol Oncol 2004 Aug;94(2):436-41 21 Citations |
| 1 | Overexpression of synuclein-gamma in pancreatic adenocarcinoma. (Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB, Chiao PJ) Cancer 2004 Jul 01;101(1):58-65 66 Citations |
| 1 | False positive diagnosis in conventional and liquid-based cervical specimens. (Mount S, Harmon M, Eltabbakh G, Uyar D, Leiman G) Acta Cytol 2004;48(3):363-71 16 Citations |
| 1 | The role of intraoperative radiotherapy in pancreatic cancer. (Crane CH, Beddar AS, Evans DB) Surg Oncol Clin N Am 2003 Oct;12(4):965-77 22 Citations |
| 1 | A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon. (Czito BG, Hong TJ, Cohen DP, Tyler DS, Lee CG, Anscher MS, Ludwig KA, Seigler HF, Mantyh C, Morse MA, Lockhart AC, Petros WP, Honeycutt W, Spector NL, Ertel PJ, Mangum SG, Hurwitz HI) Int J Radiat Oncol Biol Phys 2004 Mar 01;58(3):779-85 7 Citations |
| 1 | Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. (Rich T, Harris J, Abrams R, Erickson B, Doherty M, Paradelo J, Small W Jr, Safran H, Wanebo HJ) Am J Clin Oncol 2004 Feb;27(1):51-6 94 Citations |
| 1 | Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. (Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ) Clin Cancer Res 2003 Dec 15;9(17):6534-44 154 Citations |
| 1 | Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. (Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB) Surgery 2003 Dec;134(6):946-54; discussion 954-5 433 Citations |
| 1 | Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. (Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin MF, Batra SK) Int J Oncol 2003 Nov;23(5):1365-71 75 Citations |
| 1 | Adenocarcinoma of the rete testis presenting in an undescended testicle. (Perry BB, Outman JE, Olsen LT, Damjanov I, Langenstroer P, Thrasher JB) J Urol 2003 Oct;170(4 Pt 1):1304 3 Citations |
| 1 | Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. (Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM) Am J Pathol 2003 Sep;163(3):1001-11 146 Citations |
| 1 | Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. (Parikh AA, Liu WB, Fan F, Stoeltzing O, Reinmuth N, Bruns CJ, Bucana CD, Evans DB, Ellis LM) Cancer 2003 Aug 15;98(4):720-9 100 Citations |
| 1 | Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma. (Whitcomb BP, Mutch DG, Herzog TJ, Rader JS, Gibb RK, Goodfellow PJ) Clin Cancer Res 2003 Jun;9(6):2277-87 95 Citations |
| 1 | Dysregulated expression of MIC-1/PDF in human prostate tumor cells. (Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF, Batra SK) Biochem Biophys Res Commun 2003 Jun 06;305(3):598-604 60 Citations |
| 1 | Positive predictive value of liquid-based and conventional cervical Papanicolaou smears reported as malignant. (Uyar DS, Eltabbakh GH, Mount SL) Gynecol Oncol 2003 May;89(2):227-32 24 Citations |
| 1 | Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis. (Fujioka S, Sclabas GM, Schmidt C, Niu J, Frederick WA, Dong QG, Abbruzzese JL, Evans DB, Baker C, Chiao PJ) Oncogene 2003 Mar 06;22(9):1365-70 152 Citations |
| 1 | The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies. (Varker KA, Phelps SH, King MM, Williams CL) Int J Oncol 2003 Mar;22(3):671-81 18 Citations |
| 1 | Pancreatic leak after left pancreatectomy is reduced following main pancreatic duct ligation. (Bilimoria MM, Cormier JN, Mun Y, Lee JE, Evans DB, Pisters PW) Br J Surg 2003 Feb;90(2):190-6 211 Citations |
| 1 | Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head. (Crane CH, Antolak JA, Rosen II, Forster KM, Evans DB, Janjan NA, Charnsangavej C, Pisters PW, Lenzi R, Papagikos MA, Wolff RA) Int J Gastrointest Cancer 2001;30(3):123-32 57 Citations |
| 1 | Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells. (Boostanfar R, Amezcua CA, Tourgeman DE, Roy S, Felix JC, Stanczyk FZ) Fertil Steril 2003 Jan;79(1):223-5 7 Citations |
| 1 | Current status of the molecular genetics of human prostatic adenocarcinomas. (Karan D, Lin MF, Johansson SL, Batra SK) Int J Cancer 2003 Jan 20;103(3):285-93 68 Citations |
| 1 | ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas. (Evans DB, Hess KR, Pisters PW) Ann Surg 2002 Nov;236(5):694; author reply 694-6 28 Citations |
| 1 | Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. (Lenzi R, Yalcin S, Evans DB, Abbruzzese JL) Cancer Invest 2002;20(4):464-72 41 Citations |
| 1 | Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. (Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB) J Clin Oncol 2002 May 15;20(10):2537-44 186 Citations |
| 2 | Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. (Firat S, Bousamra M, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):1047-57 174 Citations |
| 1 | Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? (Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA) Int J Radiat Oncol Biol Phys 2002 Apr 01;52(5):1293-302 201 Citations |
| 1 | Tumor localization and image registration of F-18 FDG coincidence detection scans with computed tomographic scans. (Aitken CL, Mahmoud F, McGuinness G, Kramer EL, Maguire GQ Jr, Noz ME) Clin Nucl Med 2002 Apr;27(4):275-82 5 Citations |
| 1 | Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation. (Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB) Oncologist 2002;7(1):34-45 80 Citations |
| 1 | The gastrin receptor promotes pancreatic growth in transgenic mice. (Yen TW, Sandgren EP, Liggitt HD, Palmiter RD, Zhou W, Hinds TR, Grippo PJ, McDonald JM, Robinson LM, Bell RH Jr) Pancreas 2002 Mar;24(2):121-9 14 Citations |
| 1 | Role of the ultrasonic surgical aspirator in gynecology. (Horowitz NS, Rader JS) Obstet Gynecol Clin North Am 2001 Dec;28(4):775-90 |
| 1 | Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. (Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL) Int J Pancreatol 2001;29(1):9-18 74 Citations |
| 1 | Multimodality management of localized pancreatic cancer. (Wayne JD, Wolff RA, Pisters PW, Evans DB) Cancer J 2001;7 Suppl 1:S35-46 12 Citations |
| 1 | Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. (Karan D, Johansson SL, Lin MF, Batra SK) Oncol Rep 2001;8(5):1123-6 5 Citations |
| 1 | Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. (Wolff RA, Evans DB, Gravel DM, Lenzi R, Pisters PW, Lee JE, Janjan NA, Charnsangavej C, Abbruzzese JL) Clin Cancer Res 2001 Aug;7(8):2246-53 186 Citations |
| 1 | Preoperative chemoradiation therapy for pancreatic cancer. (Evans DB, Pisters PW) Surg Clin North Am 2001 Jun;81(3):709-13 3 Citations |
| 1 | Neoadjuvant strategies for pancreatic cancer. (Evans DB, Wolff RA, Crane CH) Oncology (Williston Park) 2001 Jun;15(6):727-37; discussion 741-4, 747 13 Citations |
| 1 | Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas. (Evans DB) J Gastrointest Surg 2001;5(1):2-5 18 Citations |
| 1 | [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression]. (Chapusot C, Assem M, Martin L, Chalabreyssse L, Benhamiche AM, Lignier MA, Chauffert B, Teyssier JR, Faivre J, Piard F) Pathol Biol (Paris) 2001 Mar;49(2):115-23 2 Citations |
| 1 | Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB) Ann Surg Oncol 2001 Mar;8(2):123-32 322 Citations |
| 1 | Cyclooxygenase-2 is overexpressed in human cervical cancer. (Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ) Clin Cancer Res 2001 Feb;7(2):429-34 314 Citations |
| 2 | Effect of treatment on quality of life among men with clinically localized prostate cancer. (Schapira MM, Lawrence WF, Katz DA, McAuliffe TL, Nattinger AB) Med Care 2001 Mar;39(3):243-53 80 Citations |
| 1 | Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. (Evans DB, Wolff RA, Hess KR) Ann Surg 2000 Nov;232(5):727 8 Citations |
| 1 | p21WAF1 expression is associated with improved survival after adjuvant chemoradiation for pancreatic cancer. (Ahrendt SA, Brown HM, Komorowski RA, Zhu YR, Wilson SD, Erickson BA, Ritch PS, Pitt HA, Demeure MJ) Surgery 2000 Oct;128(4):520-30 29 Citations |
| 1 | The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. (Pearson AS, Chiao P, Zhang L, Zhang W, Larry L, Katz RL, Evans DB, Abbruzzese JL) Int J Oncol 2000 Aug;17(2):381-5 38 Citations |
| 1 | Gut peptide receptor expression in human pancreatic cancers. (Ehlers RA, Kim Sh, Zhang Y, Ethridge RT, Murrilo C, Hellmich MR, Evans DB, Townsend CM Jr, Mark Evers B) Ann Surg 2000 Jun;231(6):838-48 67 Citations |
| 1 | Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. (Sheinin Y, Kállay E, Wrba F, Kriwanek S, Peterlik M, Cross HS) J Histochem Cytochem 2000 May;48(5):595-602 114 Citations |
| 1 | Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. (Lodge JP, Ammori BJ, Prasad KR, Bellamy MC) Ann Surg 2000 Apr;231(4):471-9 140 Citations |
| 1 | Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents. (Pisters PW, Hudec WA, Lee JE, Raijman I, Lahoti S, Janjan NA, Rich TA, Crane CH, Lenzi R, Wolff RA, Abbruzzese JL, Evans DB) J Clin Oncol 2000 Feb;18(4):860-7 81 Citations |
| 1 | Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls. (Neuman RJ, Huettner PC, Li L, Mardis ER, Duffy BF, Wilson RK, Rader JS) Obstet Gynecol 2000 Jan;95(1):134-40 24 Citations |
| 1 | Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma. (Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM) J Clin Oncol 1999 Aug;17(8):2403-11 91 Citations |
| 1 | Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. (Bold RJ, Charnsangavej C, Cleary KR, Jennings M, Madray A, Leach SD, Abbruzzese JL, Pisters PW, Lee JE, Evans DB) J Gastrointest Surg 1999;3(3):233-43 114 Citations |
| 1 | Prognostic factors in resectable pancreatic cancer: p53 and bcl-2. (Bold RJ, Hess KR, Pearson AS, Grau AM, Sinicrope FA, Jennings M, McConkey DJ, Bucana CD, Cleary KR, Hallin PA, Chiao PJ, Abbruzzese JL, Evans DB) J Gastrointest Surg 1999;3(3):263-77 45 Citations |
| 1 | Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA. (Wang W, Abbruzzese JL, Evans DB, Chiao PJ) Oncogene 1999 Aug 12;18(32):4554-63 149 Citations |
| 1 | Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. (Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W, Breslin T, Abbruzzese JL, Evans DB) Ann N Y Acad Sci 1999 Jun 30;880:31-7 29 Citations |
| 1 | Chemoradiation for localized pancreatic cancer: another perspective. (Evans DB, Abbruzzese JL) Ann Surg Oncol 1999;6(1):4-7 4 Citations |
| 1 | Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study. (Duggan BD, Felix JC, Muderspach LI, Gebhardt JA, Groshen S, Morrow CP, Roman LD) Am J Obstet Gynecol 1999 Feb;180(2 Pt 1):276-82 108 Citations |
| 1 | Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma. (Kuniyasu H, Ellis LM, Evans DB, Abbruzzese JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E, Fidler IJ) Clin Cancer Res 1999 Jan;5(1):25-33 117 Citations |
| 1 | The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. (Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ) Clin Cancer Res 1999 Jan;5(1):119-27 647 Citations |
| 1 | Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas. (Evans DB, Pisters PW, Lee JE, Bold RJ, Charnsangavej C, Janjan NA, Wolff RA, Abbruzzese JL) J Hepatobiliary Pancreat Surg 1998;5(3):242-50 42 Citations |
| 1 | Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. (Bouvet M, Bold RJ, Lee J, Evans DB, Abbruzzese JL, Chiao PJ, McConkey DJ, Chandra J, Chada S, Fang B, Roth JA) Ann Surg Oncol 1998 Dec;5(8):681-8 119 Citations |
| 1 | Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. (Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB) J Clin Oncol 1998 Dec;16(12):3843-50 226 Citations |
| 1 | Gene therapy and pancreatic cancer. (Pearson AS, Bouvet M, Evans DB, Roth JA) Front Biosci 1998 Nov 01;3:E230-7 25 Citations |
| 1 | Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Breslin TM, Janjan NA, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Evans DB) Front Biosci 1998 Nov 01;3:E193-203 21 Citations |
| 2 | Molecular metastases in stage I pancreatic cancer: improved survival with adjuvant chemoradiation. (Demeure MJ, Doffek KM, Komorowski RA, Redlich PN, Zhu YR, Erickson BA, Ritch PS, Pitt HA, Wilson SD) Surgery 1998 Oct;124(4):663-9 49 Citations |
| 1 | Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Miller AR, Pisters PW, Lee JE, Janjan NA, Abbruzzese JL, Evans DB) Hepatogastroenterology 1998;45(21):624-33 9 Citations |
| 1 | Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. (Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB) Eur J Cancer 1998 Feb;34(3):337-40 161 Citations |
| 1 | Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features. (Huettner PC, Gerhard DS, Li L, Gersell DJ, Dunnigan K, Kamarasova T, Rader JS) Hum Pathol 1998 Apr;29(4):364-70 37 Citations |
| 1 | Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. (Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, Abbruzzese JL, Evans DB) Surg Oncol Clin N Am 1998 Jan;7(1):183-97 20 Citations |
| 1 | Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. (Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ) Cancer Res 1997 Sep 15;57(18):3929-34 146 Citations |
| 1 | Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB) J Clin Oncol 1997 Mar;15(3):928-37 505 Citations |
| 1 | Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. (Evans DB, Lee JE, Pisters PW, Charnsangavej C, Ellis LM, Chiao PJ, Lenzi R, Abbruzzese JL) Cancer Treat Res 1997;90:109-25 31 Citations |
| 1 | [Experience with surgery for synchronous double cancer of rectum and lung detected after long-term follow-up for pneumoconiosis]. (Tsuji K, Hori K, Kimura S, Takagaki M, Nakai M, Kohmoto T, Ando T, Kuyama A) Kyobu Geka 1996 Dec;49(13):1130-3 |
| 1 | bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome. (Sinicrope FA, Evans DB, Leach SD, Cleary KR, Fenoglio CJ, Lee JJ, Abbruzzese JL) Clin Cancer Res 1996 Dec;2(12):2015-22 55 Citations |
| 1 | Improving MR quantification of regional blood volume with intravascular T1 contrast agents: accuracy, precision, and water exchange. (Donahue KM, Weisskoff RM, Chesler DA, Kwong KK, Bogdanov AA Jr, Mandeville JB, Rosen BR) Magn Reson Med 1996 Dec;36(6):858-67 134 Citations |
| 1 | Palliation of inoperable esophageal carcinoma with the Wallstent endoprosthesis. (Feins RH, Johnstone DW, Baronos ES, O'Neil SM) Ann Thorac Surg 1996 Dec;62(6):1603-7 20 Citations |
| 1 | Association of gastric adenocarcinoma with the HLA class II gene DQB10301. (Lee JE, Lowy AM, Thompson WA, Lu M, Loflin PT, Skibber JM, Evans DB, Curley SA, Mansfield PF, Reveille JD) Gastroenterology 1996 Aug;111(2):426-32 79 Citations |
| 1 | Inverted papilloma associated with squamous cell carcinoma and adenocarcinoma: case report and review of the literature. (Kerschner JE, Futran ND, Chaney V) Am J Otolaryngol 1996;17(4):257-9 11 Citations |
| 1 | Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. (Evans DB, Frazier ML, Charnsangavej C, Katz RL, Larry L, Abbruzzese JL) Ann Surg Oncol 1996 May;3(3):241-6 23 Citations |
| 1 | Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT. (Loyer EM, David CL, Dubrow RA, Evans DB, Charnsangavej C) Abdom Imaging 1996;21(3):202-6 134 Citations |
| 1 | The need for standardized pathologic staging of pancreaticoduodenectomy specimens. (Staley CA, Cleary KR, Abbruzzese JL, Lee JE, Ames FC, Fenoglio CJ, Evans DB) Pancreas 1996 May;12(4):373-80 104 Citations |
| 1 | Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. (Frazier ML, Fernández E, de Llorens R, Brown NM, Pathak S, Cleary KR, Abbruzzese JL, Berry K, Olive M, Le Maistre A, Evans DB) Int J Pancreatol 1996 Feb;19(1):31-8 30 Citations |
| 1 | Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. (Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar AK, Fenoglio CJ, Lee JE, Evans DB) Ann Surg 1996 Feb;223(2):154-62 371 Citations |
| 1 | Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique. (Evans DB, Lee JE, Leach SD, Fuhrman GM, Cusack JC Jr, Rich TA) Adv Surg 1996;29:235-62 21 Citations |
| 1 | Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. (Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB) Am J Surg 1996 Jan;171(1):118-24; discussion 124-5 225 Citations |
| 1 | Preoperative chemoradiation for adenocarcinoma of the pancreas: excessive toxicity of prophylactic hepatic irradiation. (Evans DB, Abbruzzese JL, Cleary KR, Buchholz DJ, Fenoglio CJ, Collier C, Rich TA) Int J Radiat Oncol Biol Phys 1995 Nov 01;33(4):913-8 32 Citations |
| 1 | Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. (Leach SD, Rose JA, Lowy AM, Lee JE, Charnsangavej C, Abbruzzese JL, Katz RL, Evans DB) Surgery 1995 Sep;118(3):472-8 91 Citations |
| 1 | Circumvention of confluence-dependent resistance in a human multi-drug-resistant colon-cancer cell line. (Garrido C, Chauffert B, Pinard D, Tibaut F, Genne P, Assem M, Dimanche-Boitrel MT) Int J Cancer 1995 Jun 09;61(6):873-9 24 Citations |
| 1 | Preoperative combined modality therapy for pancreatic cancer. (Rich TA, Evans DB) World J Surg 1995;19(2):264-9 31 Citations |
| 1 | Fine needle aspiration of the pancreas. In quest of accuracy. (Robins DB, Katz RL, Evans DB, Atkinson EN, Green L) Acta Cytol 1995;39(1):1-10 |
| 1 | Resection for cure of carcinoma of the colon directly invading the duodenum or pancreatic head. (Curley SA, Evans DB, Ames FC) J Am Coll Surg 1994 Nov;179(5):587-92 66 Citations |
| 1 | Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. (Cusack JC Jr, Fuhrman GM, Lee JE, Evans DB) Am J Surg 1994 Oct;168(4):352-4 88 Citations |
| 1 | Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells. (Assem M, Bonvalot S, Beltramo JL, Garrido C, Dimanche-Boitrel MT, Genne P, Rebibou JM, Caillot D, Chauffert B) Br J Cancer 1994 Oct;70(4):631-5 22 Citations |
| 1 | Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma. (Duggan BD, Felix JC, Muderspach LI, Tsao JL, Shibata DK) Cancer Res 1994 Mar 15;54(6):1604-7 82 Citations |
| 1 | Clinical manifestations of vasculitis in patients with solid tumors. A case report and review of the literature. (Kurzrock R, Cohen PR, Markowitz A) Arch Intern Med 1994 Feb 14;154(3):334-40 100 Citations |
| 1 | Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. (Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ, Evans DB) Am J Surg 1994 Jan;167(1):104-11; discussion 111-3 233 Citations |
| 1 | Sweet syndrome in patients with solid tumors. (Cohen PR, Holder WR, Tucker SB, Kono S, Kurzrock R) Cancer 1993 Nov 01;72(9):2723-31 141 Citations |
| 1 | Isolated splenic metastases from colon carcinoma. (Thomas SM, Fitzgerald JB, Pollock RE, Evans DB) Eur J Surg Oncol 1993 Oct;19(5):485-90 45 Citations |
| 1 | Intraoperative radiation therapy following pancreaticoduodenectomy. (Evans DB, Termuhlen PM, Byrd DR, Ames FC, Ochran TG, Rich TA) Ann Surg 1993 Jul;218(1):54-60 52 Citations |
| 1 | Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. (Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC) Arch Surg 1992 Nov;127(11):1335-9 629 Citations |
| 1 | Human cell line from an adenocarcinoma of the ampulla of Vater. (Frazier ML, Brown N, Pathak S, Mackay B, Cleary K, Olive M, Byrd DR, Evans DB, Levin B) In Vitro Cell Dev Biol 1992 Mar;28A(3 Pt 1):149-53 7 Citations |
| 1 | Use of Dexon Mesh for abdominal partitioning above the peritoneal reflection. (Evans DB, Shumate CR, Ames FC, Rich TA) Dis Colon Rectum 1991 Sep;34(9):833-5 5 Citations |
| 1 | Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique. (Evans DB, Byrd DR, Mansfield PF) Am J Clin Oncol 1991 Aug;14(4):359-64 17 Citations |
| 1 | Adenocarcinoma of the pancreas: current management of resectable and locally advanced disease. (Evans DB, Rich TA, Byrd DR, Ames FC) South Med J 1991 May;84(5):566-70 24 Citations |
| 1 | Orbital metastasis as the presenting sign of adenocarcinoma of the breast. (Glazer LC, Harris GJ, Simons KB) Ophthalmic Plast Reconstr Surg 1991;7(4):252-5 28 Citations |
| 2 | Eccrine porocarcinoma. (Matloub HS, Cunningham MW, Yousif NJ, Sanger JR, Romano JA, Choi HY) Ann Plast Surg 1988 Apr;20(4):351-5 27 Citations |
| 1 | Osteonecrosis, fractures, and protrusio acetabuli secondary to x-irradiation therapy for prostatic carcinoma. (Csuka M, Brewer BJ, Lynch KL, McCarty DJ) J Rheumatol 1987 Feb;14(1):165-70 27 Citations |
| 1 | Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung. (Liang JC, Kurzrock R, Gutterman JU, Gallick GE) Cancer Genet Cytogenet 1986 Oct;23(2):183-8 29 Citations |
| 1 | Differential expression of p21ras gene products among histological subtypes of fresh primary human lung tumors. (Kurzrock R, Gallick GE, Gutterman JU) Cancer Res 1986 Mar;46(3):1530-4 58 Citations |
